2. 您的位置
3. 首页
4. 会议论文
5. Progression of central nervous system metastases in advanced non-small cell lung cancer effectively

Progression of central nervous system metastases in advanced non-small cell lung cancer effectively

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：yuantian723

【摘 要】

：

Objective: Central nervous system (CNS) progression is frequently detected in patients with favorable initial responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs), but

【作 者】

：

Yongmei Liu Qian Zhao Xiaojuan Zhou Yong Xu Youling Gong Meijuan Huang Feng Peng Lin Zhou Jiang Zhu Jin Wang Li Ren Mei Hou You Lu Yongmei Liu 

【机 构】

：

Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University

【出 处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年4期

【关键词】

：

Non-small cell lung cancer gefitinb central nervous 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: Central nervous system (CNS) progression is frequently detected in patients with favorable initial responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs), but data are incomplete with respect to clinical features and prognostic factors of CNS failure in this population.

其他文献

Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent SCLC:CA209-032 (N

Objective: Patients (pts) with SCLC respond to initial platinum (PLT) based chemotherapy (CT), but rapidly progress.Combined blockade of programmed death-1 (PD-1) and cytotoxic T-lymphocyte antigen-4

会议

nivolumabipilimumabsmall cell lung cancer

Erlotinib as Neoadjuvant Treatment in Endobronchial Ultrasound Confirmed Stage ⅢA-N2 Non-small Cell

Background: Concurrent chemoradiation therapy or induction chemotherapy plus surgery were considered as standard treatment to non-small-cell lung cancer (NSCLC) in stage ⅢA-N2, but the side effect bec

会议

NSCLC

18F-FDG PET maximal standardized uptake and serum CEA levels before initial treatment are associated

Objective: Several phase Ⅲ studies demonstrated that, compared with traditional chemotherapy, epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), as first-linetreatments, contribu

会议

NSCLCEGFR-TKIserum CEA

Survival analysis of non-small cell lung cancer using TKI treatment-- A multi-center retrospective s

Objective: To assess differences in overall survival among patients with NSCLC using TKIs in first or second line treatment and different TKIs.Method: Collecting patients data in CRF and use SPSS soft

会议

lung cancerTyrosine kinase inhibitorSurvival ana

Efficacy and safety of nitroglycerin combined with chemotherapy in the elderly patients with advance

Objective: To investigate the efficacy and safety of the treatment of nitroglycerin combined with docetaxel/carboplatin chemotherapy for the elderly patients with advanced non-small cell lung cancer (

会议

Geriatric OncologyNSCLCNitroglycerin

消癌平注射液改善非小细胞肺癌细胞对gefitinib和erlotinib双重耐药的作用及机理

目的：通过吉非替尼(gefitinib)和厄洛替尼(erlotinib)双重耐药非小细胞肺癌(NSCLC)细胞HCC827/ER研究消癌平注射液(XAP)改善gefitinib和erlotinib耐药的作用及机理。方法：通过erlotinib 长期诱导形成耐药细胞株HCC827/ER,MTT检测细胞增殖,Taqman探针实时荧光定量PCR检测Met基因拷贝数,Western blot法检测细胞蛋白

会议

非小细胞肺癌消癌平注射液gefitinib和erlotinib双重耐药

Identifying the Role of Protein kinase CK2 in the Radiosensitivity of Non-small Cell Lung Cancer

Objective: Proteinkinase CK2 (also known ascasein kinase) is a highlyconserved seine/threonine protein kinase, which is ubiquitously expressed inmammalian cells.CK2 has been implicated in multiple phy

会议

Protein kinase CK2RadiosensitivityNon small cell

Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma

Objective: Stem-like cells in solid tumors are purported to contribute to cancer development and poor treatment outcome.The abilities to self-renew, differentiate, and resist anticancer therapies are

会议

lung cancerstem cellvitamin D

Consolidation Chemotherapy may Improve Survival for Patients with Locally Advanced Non-small-cell Lu

Objective: For patients with locally advanced non-small-cell lung cancer (LA-NSCLC), the role of consolidation chemotherapy (CCT) following concurrent chemoradiotherapy (CRT) is partially defined.

会议

Locally advanced non-small-cell lung cancerConsol

CACNA2D1 Is a Novel Biomarker for Tumor Initiating Cells and Has Therapeutic Effect in Non-Small Cel

Objective: Tumor initiating cells (TICs) are a small subpopulation within cancer that is thought to be resistant to conventional therapiesand capable of reinitiating tumors.

会议

Tumor initiating cellsnon small lung cancertarg